Stephen Kahl, PhD
Professor Emeritus
Pharmaceutical Chemistry
School of Pharmacy

Grants and Projects

Show all (7) Hide

• Nonclinical development of Nervelight, an intra-operative peripheral nerve imaging agent, NIH, 2017-2021
• Bio-Organic Biomedical Mass Spectrometry Resource, NIH, 1982-2015
• In vivo feasibility of a peripheral nerve imaging agent, NIH, 2013-2015
• Program for Development of BNCT Agents, NIH, 2000-2012
• Boronated Tumor-seeking Porphyrins--Synthesis &Testing, NIH, 1985-1997
• Design/synthesis of Boronated Tumor-seeking Macrocyclic, NIH, 1991-1996
• Boronated Lipoprotein Site Specific Radiochemotherapy, NIH, 1986-1990

Publications (6)

Top publication keywords:
Boron CompoundsAntigens, Polyomavirus TransformingMaximum Tolerated DoseAldehydesDeuteroporphyrinsPhenylalanineBoranesBoronAnionsBoron Neutron Capture TherapyLipoproteinsMetalloporphyrinsBoronic AcidsRats, Inbred F344Porphyrins

• Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins.
  Journal of medicinal chemistry 2007 Koo MS, Ozawa T, Santos RA, Lamborn KR, Bollen AW, Deen DF, Kahl SB
• Simple, high-yield methods for the synthesis of aldehydes directly from o-, m-, and p-carborane and their further conversions.
  Inorganic chemistry 2005 Dozzo P, Kasar RA, Kahl SB
• Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
  International journal of radiation oncology, biology, physics 2005 Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF
• Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
  Molecular pharmaceutics 2005 Dagrosa MA, Viaggi M, Rebagliati RJ, Batistoni D, Kahl SB, Juvenal GJ, Pisarev MA
• Synthesis, characterization, and plasma lipoprotein association of a nucleus-targeted boronated porphyrin.
  Journal of medicinal chemistry 2005 Dozzo P, Koo MS, Berger S, Forte TM, Kahl SB
• In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts.
  Molecular pharmaceutics 2004 Ozawa T, Santos RA, Lamborn KR, Bauer WF, Koo MS, Kahl SB, Deen DF